Quadrant Capital Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.27M | Sell |
5,105
-233
| -4% | -$104K | 0.08% | 200 |
|
|
2025
Q1 | $2.59M | Buy |
5,338
+2,841
| +114% | +$1.38M | 0.1% | 134 |
|
|
2024
Q4 | $1.01M | Buy |
2,497
+12
| +0.5% | +$4.83K | 0.07% | 191 |
|
|
2024
Q3 | $1.16M | Buy |
2,485
+4
| +0.2% | +$1.86K | 0.08% | 181 |
|
|
2024
Q2 | $1.16M | Buy |
2,481
+135
| +6% | +$63.3K | 0.09% | 166 |
|
|
2024
Q1 | $981K | Buy |
2,346
+27
| +1% | +$11.3K | 0.08% | 185 |
|
|
2023
Q4 | $944K | Buy |
2,319
+72
| +3% | +$29.3K | 0.08% | 178 |
|
|
2023
Q3 | $781K | Sell |
2,247
-14
| -0.6% | -$4.87K | 0.08% | 186 |
|
|
2023
Q2 | $796K | Sell |
2,261
-80
| -3% | -$28.2K | 0.08% | 179 |
|
|
2023
Q1 | $738K | Buy |
2,341
+336
| +17% | +$106K | 0.08% | 192 |
|
|
2022
Q4 | $579K | Sell |
2,005
-7
| -0.3% | -$2.02K | 0.07% | 212 |
|
|
2022
Q3 | $583K | Buy |
2,012
+161
| +9% | +$46.7K | 0.08% | 184 |
|
|
2022
Q2 | $522K | Buy |
1,851
+329
| +22% | +$92.8K | 0.07% | 211 |
|
|
2022
Q1 | $397K | Buy |
1,522
+100
| +7% | +$26.1K | 0.05% | 276 |
|
|
2021
Q4 | $312K | Buy |
1,422
+230
| +19% | +$50.5K | 0.04% | 329 |
|
|
2021
Q3 | $216K | Sell |
1,192
-148
| -11% | -$26.8K | 0.03% | 368 |
|
|
2021
Q2 | $270K | Sell |
1,340
-112
| -8% | -$22.6K | 0.04% | 301 |
|
|
2021
Q1 | $312K | Buy |
1,452
+32
| +2% | +$6.88K | 0.05% | 252 |
|
|
2020
Q4 | $336K | Buy |
1,420
+155
| +12% | +$36.7K | 0.06% | 204 |
|
|
2020
Q3 | $344K | Buy |
1,265
+16
| +1% | +$4.35K | 0.08% | 170 |
|
|
2020
Q2 | $363K | Sell |
1,249
-1,263
| -50% | -$367K | 0.08% | 172 |
|
|
2020
Q1 | $594K | Buy |
2,512
+406
| +19% | +$96K | 0.1% | 177 |
|
|
2019
Q4 | $435K | Buy |
2,106
+229
| +12% | +$47.3K | 0.05% | 359 |
|
|
2019
Q3 | $305K | Buy |
1,877
+65
| +4% | +$10.6K | 0.05% | 428 |
|
|
2019
Q2 | $319K | Buy |
1,812
+266
| +17% | +$46.8K | 0.05% | 376 |
|
|
2019
Q1 | $270K | Buy |
1,546
+693
| +81% | +$121K | 0.05% | 393 |
|
|
2018
Q4 | $125K | Buy |
853
+169
| +25% | +$24.8K | 0.03% | 526 |
|
|
2018
Q3 | $122K | Buy |
684
+31
| +5% | +$5.53K | 0.03% | 346 |
|
|
2018
Q2 | $99K | Sell |
653
-48
| -7% | -$7.28K | 0.03% | 411 |
|
|
2018
Q1 | $100K | Buy |
701
+74
| +12% | +$10.6K | 0.04% | 412 |
|
|
2017
Q4 | $85K | Buy |
627
+3
| +0.5% | +$407 | 0.03% | 454 |
|
|
2017
Q3 | $87K | Buy |
624
+37
| +6% | +$5.16K | 0.04% | 430 |
|
|
2017
Q2 | $69K | Buy |
587
+65
| +12% | +$7.64K | 0.03% | 448 |
|
|
2017
Q1 | $51K | Buy |
522
+64
| +14% | +$6.25K | 0.02% | 572 |
|
|
2016
Q4 | $29K | Sell |
458
-97
| -17% | -$6.14K | 0.01% | 628 |
|
|
2016
Q3 | $39K | Buy |
555
+52
| +10% | +$3.65K | 0.03% | 522 |
|
|
2016
Q2 | $36K | Buy |
503
+66
| +15% | +$4.72K | 0.02% | 508 |
|
|
2016
Q1 | $31K | Sell |
437
-518
| -54% | -$36.7K | 0.02% | 536 |
|
|
2015
Q4 | $116K | Sell |
955
-22
| -2% | -$2.67K | 0.08% | 224 |
|
|
2015
Q3 | $99K | Buy |
977
+85
| +10% | +$8.61K | 0.07% | 243 |
|
|
2015
Q2 | $109K | Buy |
+892
| New | +$109K | 0.07% | 236 |
|